Summary
The effect of obesity and fat distribution on survival of breast cancer patients was studied prospectively in 241 women with a natural menopause who participated in a breast cancer screening project, the DOM-project in Utrecht, The Netherlands. Mean follow-up time was 9.1 years and endpoint of interest was death from breast cancer. Fat distribution was assessed by contrasting groups of subscapular and triceps skinfold thickness.
No significant differences in survival time between more obese (Quetelet's index ≥ 26 kg/m2) and leaner (Quetelet's index < 26 kg/m2) patients or between patients with central fat distribution and patients with peripheral fat distribution were observed. Analyses were stratified by axillary node status, estrogen receptor status, and way of detection (by first screening or afterwards). Results of the stratified analyses were suggestive of a modifying effect of these factors.
The absence of an association between obesity and survival time might be explained by two counteracting mechanisms. On the one hand obesity might be related to impaired survival, due to a tumor growth promoting effect of extra-ovarian estrogens. On the other hand obesity might be related to improved survival in a screened population, because obese patients profit more from screening by earlier detection of tumors than leaner counterparts.
References
de Waard F: The epidemiology of breast cancer, review and prospects. Int J Cancer 4: 577–586, 1969
Osler M: Obesity and cancer. A review of epidemiological studies on the relationship of obesity to cancer of the colon, rectum, prostate, breast, ovaries, and endometrium. Dann Med Bull 34: 267–274, 1987
Törnberg SA, Holm LE, Cartensen JM: Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncologica 27: 31–37, 1988
Tretli S: Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 44: 23–30, 1989
Parazzini F, La Vecchia C, Negri E, Bruzzi P, Palli D, Boyle P: Anthropometric variables and risk of breast cancer. Int J Cancer 45: 397–402, 1990
den Tonkelaar I, Seidell JC, Collette HJA, de Waard F: Obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women participating in the diagnostic investigation of mammary cancer project. Cancer 69: 2663–2667, 1992
London SJ, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE: Prospective study of relative weight, height, and risk of breast cancer. JAMA 262: 2853–2858, 1989
Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB, Splansky GL, Anderson KM, Helsel WE: Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst 82: 286–290, 1990
Donegan W, Hartz AJ, Rimm AA: The association of body weight with recurrent cancer of the breast. Cancer 41: 1590–1594, 1978
Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW: Body weight and prognosis in breast cancer. JNCI 67: 785–789, 1981
Tartter PI, Papatestas AE, Ioannovich J, Mulvihill MN, Lesnick G, Aufses AH: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47: 2222–2227, 1981
de Waard F, van der Velden JW, de Does M: De invloed van het relatieve lichaamsgewicht op de prognose van borstkanker bij vrouwen. Ned Tijdschr Geneeskd 129: 454–459, 1985
Eberlein T, Simon R, Fisher S, Lippman ME: Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat 5: 81–86, 1985
Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D: Body size and survival in premenopausal breast cancer. Br J Cancer 51: 691–697, 1985
Newman SC, Miller AB, Howe GR: A study of the effect of weight and dietary fat on breast cancer survival time. Am J Epidemiol 123: 767–774, 1986
McNee RK, Mason BH, Neave LM, Kay RG: Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand. Breast Cancer Res Treat 9: 145–150, 1987
Hebert JR, Augustine A, Barone J, Kabat GC, Kinne DW, Wynder EL: Weight, height and body mass index in the prognosis of breast cancer: early results of a prospective study. Int J Cancer 42: 315–318, 1988
Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS: Body size reproductive factors and breast cancer survival. Prev Med 17: 634–642, 1988
Lees AW, Jenkins HJ, May CL, Cherian G, Lam EWH, Hanson J: Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13: 143–151, 1989
Nomura AMY, Le Marchand L, Kolonel LN, Hankin JH: The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii. Breast Cancer Res Treat 18: 135–141, 1991
Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW: Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Int Med 116: 26–32, 1992
Törnberg S, Carstensen J: Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J Cancer 14: 2025–2030, 1993
Rohan TE, Hiller JE, McMichael AJ: Dietary factors and survival from breast cancer. Nutr Cancer 20: 167–177, 1993
Sohrabi A, Sandoz J, Spratt JS, Polk HC: Recurrence of breast cancer - Obesity, tumor size, and axillary lymph node metastases. JAMA 244: 264–265, 1980
Lapidus L, Helgesson O, Merck C, Björntorp P: Adipose tissue distribution and female carcinomas - a 12 year follow-up of participants in the population study of women in Gothenburg, Sweden. Int J Obesity 12: 361–368, 1988
Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB: Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131: 794–803, 1990
Schapira DV, Kumar NB, Lyman GH, Cox CE: Abdominal obesity and breast cancer risk. Ann Intern Med 112: 182–186, 1990
Bruning PF, Bonfrèr JMG, Hart AAM, van Noord PAH, van der Hoeven H, Collette HJA, Battermann JJ, de Jong-Bakker M, Nooijen WJ, de Waard F: Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 51: 14–19, 1992
Sellers TA, Kushi LH, Potter JD, Kaye SA, Nelson CL, McGovern PG, Folsom AR: Effect of family history, body-fat distribution, and reproductive factors on the risk of post-menopausal breast cancer. N Engl J Med 326: 1323–1329, 1992
Soennichsen AC, Lindlacher U, Richter WO, Schwandt P: Adipositas, Körperfettverteilung und Inzidenz von Mamma-, Zervix-, Endometrium- und Ovarialkarzinomen. D Med Woch 115: 1906–1910, 1990
Petrek JA, Peters M, Cirrincione C, Rhodes D, Bajournas D: Is body fat topography a risk factor for breast cancer? Ann Intern Med 118: 356–362, 1993
Schapira DV, Kumar NB, Lyman GH, Cox CE: Obesity and body fat distribution and breast cancer prognosis. Cancer 67: 523–528, 1991
de Waard F, Collette HJA, Rombach JJ, Baanders-van Halewijn EA, Honing C: The DOM project for the early detection of breast cancer, Utrecht, The Netherlands. J Chron Dis 37: 1–44, 1984
Collette C, Collette HJA, Fracheboud J, Slotboom BJ, de Waard F: Evaluation of a breast cancer screening programme- The DOM project. Eur J Cancer 12: 1985–1988, 1992
Statistics and Epidemiology, Research Corporation, Seattle, 1990
Walter SD, Day NE: Estimation of the duration of a preclinical disease state using screening data. Am J Epidemiol 118: 865–886, 1983
de Waard F, Cornelis JP, Aoki K, Yoshida M: Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi prefecture, Japan. Cancer 40: 1269–1275, 1977
Williams G, Howell A, Jones M: The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer 58: 631–634, 1988
Verreault R, Brisson J, Deschênes L, Naud F: Body weight and prognostic indicators in breast cancer. Am J Epidemiol 129: 260–268, 1989
Howson CP, Kinne D, Wynder EL: Body weight, serum cholesterol and stage of primary breast cancer. Cancer 58: 2372–2381, 1986
Ingram D, Nottage E, Sparrow L, Roberts A, Willcox D: Obesity and breast disease - The role of the female sex hormones. Cancer 64: 1049–1053, 1989
Stanford JL, Szklo M, Brinton LA: Estrogen receptors and breast cancer. Epidemiol Rev 8: 42–59, 1986
Kreiger N, King WD, Rosenberg L, Clarke EA, Palmer JR, Shapiro S: Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1: 513–523, 1991
Aamdal S, Bormer O, Jorgensen O, Host H, Eliassen G, Kaalhus O, Pihl A: Estrogen receptors and long-term prognosis in breast cancer. Cancer 53: 2525–2529, 1984
Adami HO, Graffman S, Lindgren A, Sällström J: Prognostic implication of estrogen receptor content in breast cancer. Breast Cancer Res Treat 5: 293–300, 1985
Raemaekers JMM, Beex LVAM, Koenders AJM, Pieters GFFM, Smals AGH, Benraad TJ, Kloppenborg PWC: Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up. Breast Cancer Res Treat 6: 123–130, 1985
Cleton FJ, Engelsman E, Nooy M: Adjuvante therapie bij patienten met operabel mammacarcinoom. Ned Tijdschr Geneeskd 130: 719–721, 1986
Repelaer van Driel OJ, Welvaart K, Stijnen T: Verbetering van overleving door adjuvante therapie bij patienten met operabel mammacarcinoom? Ned Tijdschr Geneeskd 130: 744–746, 1986
Enriori CL, Reforzo-Membrives J: Peripheral aromatization as a risk factor for breast cancer and endometrial cancer in postmenopausal women: a review. Gynecol Oncol 17: 1–21, 1984
Ota DM, Jones LA, Jackson GL, Jackson PM, Kemp K, Bauman D: Obesity: Non-protein bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients. Cancer 57: 558–562, 1986
Brekelmans CTM, Peeters PHM, Faber JAJ, Deurenberg JJM, Collette HJA: The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 30: 223–232, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
den Tonkelaar, I., de Waard, F., Seidell, J.C. et al. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Tr 34, 129–137 (1995). https://doi.org/10.1007/BF00665785
Issue Date:
DOI: https://doi.org/10.1007/BF00665785